A newly identified COVID-19 variant, known as BA.3.2, has been detected across multiple U.S. states, prompting increased monitoring by federal health officials.

According to the Centers for Disease Control and Prevention, the variant has been identified in at least 25 states through a combination of clinical samples, traveler screenings, and wastewater surveillance. The strain has also been reported in more than 20 countries, indicating a broader international presence.

BA.3.2 is considered genetically distinct from earlier variants that have circulated widely in the United States since 2024. Researchers say the strain contains a high number of mutations in its spike protein, the part of the virus responsible for entering human cells.

Health officials noted that the variant has shown what are described as “immune escape” characteristics, meaning certain mutations may reduce the effectiveness of existing immunity from prior infection or vaccination. However, experts say it remains too early to determine how severe or transmissible the variant may be.

The strain was first identified in the United States in mid-2025 in a traveler arriving from Europe and has since appeared in additional samples, including airport wastewater testing. In some European countries, the variant accounted for a notable share of detected cases late last year into early 2026.

Despite these developments, public health authorities emphasize that overall prevalence remains relatively low. Researchers say continued genomic surveillance will be critical to track how the variant evolves and whether it becomes a more significant factor in future outbreaks.